Image source: Visual China
(This article continues to be updated. The time shown at the beginning of the article is the update time of this article.)
worldwide
0800[The total number of confirmed cases worldwide exceeds 234 million]
According to the epidemic tracking data of Johns Hopkins University, as of 8:30 am on October 2, Beijing time, there were a total of 234,234,133 confirmed cases of new coronary pneumonia worldwide, a total of 4,789,893 deaths, and more than 6.26 billion doses of vaccination.
Kitami
0830[New crown treatment oral drugs are coming: the risk of hospitalization or death is reduced by nearly 50%]
On October 1, local time, the US pharmaceutical giant Merck announced that its experimental oral drug “molnupiravir” for the new crown is under development, which can reduce the hospitalization or mortality of severe and high-risk patients by about 50%.
Image source: Visual China
(This article continues to be updated. The time shown at the beginning of the article is the update time of this article.)
worldwide
0800[The total number of confirmed cases worldwide exceeds 234 million]
According to the epidemic tracking data of Johns Hopkins University, as of 8:30 am on October 2, Beijing time, there were a total of 234,234,133 confirmed cases of new coronary pneumonia worldwide, a total of 4,789,893 deaths, and more than 6.26 billion doses of vaccination.
Kitami
0830[New crown treatment oral drugs are coming: the risk of hospitalization or death is reduced by nearly 50%]
On October 1, local time, the US pharmaceutical giant Merck announced that its experimental oral drug “molnupiravir” for the new crown is under development, which can reduce the hospitalization or mortality of severe and high-risk patients by about 50%.Return to Sohu to see more
Editor:
Disclaimer: The opinions of this article only represent the author himself. Sohu is an information publishing platform. Sohu only provides information storage space services.
.